📰 Drug Launch News
Drug Launch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Drug Launch. Real-time updates on events, politics, business and more.
April 22, 2024
Incred Equities estimates Mirabegron to be a $75-80 million opportunity for Zydus Lifesciences, as the company also enjoys a 180-day exclusivity period
April 21, 2022
It wasn’t supposed to be this way. Zealand Pharma should be in the honeymoon glow of its first drug launch with a drug approved less than a year ago.
March 8, 2022
Nearly five years after unveiling the first clinical data for its BCMA-targeted CAR-T therapy, Legend Biotech has transitioned into a commercial company with an FDA approval for Carvykti and Johnso
March 4, 2022
Hutchmed’s very first employee and longtime CEO, Chrisian Hogg, is retiring after a 15-year run, just as the Chinese company is prepping to break into the U.S. market.
February 2, 2022
As Novartis creeps toward losing exclusivity for some big-selling medicines, the drugmaker is counting on new launches to replace lost sales and fuel growth. One such launch is cholesterol drug Leqvio, and execs said Wednesday the company is laying the groundwork for a medicine with "multiblockbuster potential."
August 26, 2021
The FDA gave a thumbs up to Ascendis Pharma’s long-acting growth hormone lonapegsomatropin-tcgd on Wednesday. Now christened Skytrofa, the drug is the first once-weekly therapy for pediatric growth hormone disorder, but a rival from Pfizer is nearing the finish line.
May 28, 2021
What was once considered the "Achilles heel" of lung cancer tumors, as Amgen puts it, now has an FDA-approved treatment in the company's KRAS inhibitor, Lumakras.
February 16, 2021
The FDA approved G1s Cosela on Friday. (FDA) Despite the ever-growing use of targeted oncology drugs, chemotherapy is still widely used in lung cancer—and it still comes with potentially severe side effects. G1 Therapeutics just won FDA approval for a therapy that can help combat one of the most serious. G1s Cosela scored a green light to reduce the bone marrow damage that can come along with chemo. Given ahead of certain chemotherapy regimens to patients with extensive-stage small-cell ...